Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis

Infection and Immunity

Volumn 83, Issue 2, 2015, Pages 534-543

  Porcella, Stephen F ^a   Carlson, John H ^a   Sturdevant, Daniel E ^a   Sturdevant, Gail L ^a   Kanakabandi, Kishore ^a   Virtaneva, Kimmo ^a   Wilder, Hannah ^a,c   Whitmire, William M ^a   Song, Lihua ^b   Caldwell, Harlan D ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; FAS ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOGEN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 20; INTERLEUKIN 24; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; RANTES; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; BACTERIAL PROTEIN; CYTOKINE; INTERLEUKIN DERIVATIVE; VIRULENCE FACTOR;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; CHLAMYDIA TRACHOMATIS; COMPARATIVE STUDY; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC CODE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; MICROARRAY ANALYSIS; MICROBIAL ATTENUATION; MODULATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRACHOMA; BIOSYNTHESIS; CD8+ T LYMPHOCYTE; CHLAMYDIASIS; GENETICS; HELA CELL LINE; IMMUNOLOGY; INFLAMMATION; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; TUMOR CELL LINE;

BACTERIAL PROTEINS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; GLYCOGEN; HELA CELLS; HUMANS; INFLAMMATION; INTERLEUKINS; PLASMIDS; TRACHOMA; VIRULENCE FACTORS;

EID: 84921340538     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02764-14     Document Type: Article

References (35)

1. Hotez PJ, Kamath A. 2009. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3:e412. http://dx.doi.org/10.1371/journal.pntd.0000412.
2. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. 2004. Global data on visual impairment in the year 2002. Bull World Health Organ 82:844-851.
3. Bébéar C, de Barbeyrac B. 2009. Genital Chlamydia trachomatis infections. Clin Microbiol Infect 15:4-10. http://dx.doi.org/10.1111/j.1469-0691.2008.02647.x.
4. Brunham RC, Rey-Ladino J. 2005. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5:149-161. http://dx.doi.org/10.1038/nri1551.
5. Vasilevsky S, Grueb G, Nardelli-Haefliger D, Baud D. 2014. Genital Chlamydia trachomatis: understanding the roles of innate and adaptive immunity in vaccine research. Clin Microbiol Rev 27:346-370. http://dx.doi.org/10.1128/CMR.00105-13.
6. Morrison RP, Belland RJ, Lyng K, Caldwell HD. 1989. Chlamydial disease pathogenesi. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 170:1271-1283.
7. Morrison RP, Lyng K, Caldwell HD. 1989. Chlamydial disease pathogenesi. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med 169:663-675.
8. Stephens RS. 2003. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 11:44-51. http://dx.doi.org/10.1016/S0966-842X(02)00011-2.
9. Watkins NG, Hadlow WJ, Moos AB, Caldwell HP. 1986. Ocular delayed hypersensitivity: a pathogenetic mechanism of Chlamydial conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A 83:7480-7484. http://dx.doi.org/10.1073/pnas.83.19.7480.
10. Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, Kupko JJ, Porcella SF, Martinez-Orengo N, Heinzen RA, Kari L, Caldwell HD. 2008. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun 76:2273-2283. http://dx.doi.org/10.1128/IAI.00102-08.
11. O'Connell CM, Ingalls RR, Andrews CW, Jr, Scurlock AM, Darville T. 2007. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 179:4027-4034. http://dx.doi.org/10.4049/jimmunol.179.6.4027.
12. Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, Carlson JH, Sturdevant GL, Lu C, Bakios LE, Randall LB, Parnell MJ, Zhong G, Caldwell HD. 2011. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 208:2217-2223. http://dx.doi.org/10.1084/jem.20111266.
13. Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, Sturdevant DE, Watkins H, Zhou B, Sturdevant GL, Porcella SF, McClarty G, Caldwell HD. 2013. Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun 81: 636-644. http://dx.doi.org/10.1128/IAI.01305-12.
14. Darville T, O'Neill JM, Andrews CWJ, Nagarajan UM, Stahl L, Ojjcius DM. 2003. Toll-like receptor-2, but not Toll-like receptor-4, is essential for development of oviduct pathology in chlamydial genital tract infection. J Immunol 171:6187-6197. http://dx.doi.org/10.4049/jimmunol.171.11.6187.
15. Dong X, Liu Y, Chang X, Lei L, Zhong G. 2014. Signaling via tumor necrosis factor receptor 1 but not Toll-like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection. Infect Immun 82:1833-1839. http://dx.doi.org/10.1128/IAI.01668-13.
16. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN. 2011. Tumor necrosis factor alpha production from CD8 T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun 79:2928-2935. http://dx.doi.org/10.1128/IAI.05022-11.
17. Mackey-Lawrence NM, Guo X, Sturdevant DE, Virtaneva K, Hernandez MM, Houpt E, Sher A, Porcella SF, Petri WAJ. 2013. Effect of the leptin receptor Q223R polymorphism on the host transcriptome following infection with Entamoeba histolytica. Infect Immun 81:1460-1470. http://dx.doi.org/10.1128/IAI.01383-12.
18. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant D, Otto M. 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc Natl Acad Sci U S A 104:9469-9474. http://dx.doi.org/10.1073/pnas.0702159104.
19. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and proven approach to multiple testing. J R Stat Soc Series B Stat Methods 57:289-300.
20. Edgar R, Domrachev M, Lash AE. 2002. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30:207-210. http://dx.doi.org/10.1093/nar/30.1.207.
21. Comanducci M, Ricci S, Cevenini R, Ratti G. 1990. Diversity of the Chlamydia trachomatis common plasmid in biovars with different pathogenicity. Plasmid 23:149-154. http://dx.doi.org/10.1016/0147-619X(90)90034-A.
22. Rockey DD. 2011. Unraveling the basic biology and clinical significance of the chlamydial plasmid. J Exp Med 208:2159-2162. http://dx.doi.org/10.1084/jem.20112088.
23. Russell M, Darville T, Chandra-Kuntal K, Smith B, Andrews CWJ, O'Connell CM. 2011. Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid. Infect Immun 79:98-107. http://dx.doi.org/10.1128/IAI.01105-10.
24. Sigar IM, Schripsema JH, Wang Y, Clarke IN, Cutcliffe LT, Seth-Smith HM, Thomson NR, Bjartling C, Unemo M, Persson K, Ramsey KH. 2014. Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model. Pathog Dis 70:61-69. http://dx.doi.org/10.1111/2049-632X.12086.
25. Heine H, Muller-Loennies S, Brade L, Lindner B, Brade H. 2003. Endotoxic activity and chemical structure of lipopolysaccharides from Chlamydia trachomatis serotypes E and L2 and Chlamydophila psittaci 6BC. Eur J Biochem 270:440-450. http://dx.doi.org/10.1046/j.1432-1033.2003.03392.x.
26. Buchholz KR, Stephens RS. 2006. Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis. Cell Microbiol 8:1768-1779. http://dx.doi.org/10.1111/j.1462-5822.2006.00747.x.
27. Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX, Anderson DJ, Fierer J, Stephens RS, Kagnoff MF. 1997. Secretion of proinflammatory cytokines by epithelial cells in response to Chlamydia infection suggests a central role for epithelial cells in chlamydial pathogenesis. J Clin Invest 99:77-87. http://dx.doi.org/10.1172/JCI119136.
28. Xia M, Bumgarner RE, Lampe MF, Stamm WE. 2003. Chlamydia trachomatis infection alters host cell transcription in diverse cellular pathways. J Infect Dis 187:424-434. http://dx.doi.org/10.1086/367962.
29. Sellami H, Said-Sadier N, Znazen A, Gdoura R, Ojcius DM, Hammami A. 2014. Chlamydia trachomatis infection increases the expression of inflammatory tumorigenic cytokines and chemokines as well as components of the Toll-like receptor and NF-B pathways in human prostate epithelial cells. Mol Cell Probes 28:147-154. http://dx.doi.org/10.1016/j.mcp.2014.01.006.
30. Burton MJ, Rajak SN, Bauer J, Weiss HA, Tolbert SB, Shoo A, Habtamu E, Manjurano A, Emerson PM, Mabey DC, Holland MJ, Bailey RL. 2011. Conjunctival transcriptome in scarring trachoma. Infect Immun 79:499-511. http://dx.doi.org/10.1128/IAI.00888-10.
31. Natividad A, Freeman TC, Jeffries D, Burton MJ, Mabey DC, Bailey RL, Holland MJ. 2010. Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. Infect Immun 78:4895-4911. http://dx.doi.org/10.1128/IAI.00844-10.
32. Fankhauser SC, Starnbach MN. 2014. PD-L1 limits the mucosal CD8T cell response to Chlamydia trachomatis. J Immunol 192:1079-1090. http://dx.doi.org/10.4049/jimmunol.1301657.
33. Olivares-Zavaleta N, Whitmire BW, Kari L, Sturdevant GL, Caldwell HD. 2014. CD8 T cells define an unexpected role in live-attenuated vaccine protective immunity against Chlamydia trachomatis infection in macaques. J Immunol 192:4648-4654. http://dx.doi.org/10.4049/jimmunol.1400120.
34. Schumacher A, Heinze K, Witte J, Poloski E, Linzke N, Woidacki K, Zenclussen AC. 2013. Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance. J Immunol 190:2650-2658. http://dx.doi.org/10.4049/jimmunol.1202698.
35. Buckner LR, Lewis ME, Greene SJ, Foster TP, Quayle AJ. 2013. Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells. Cytokine 63:151-165. http://dx.doi.org/10.1016/j.cyto.2013.04.022.